Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis - Divided Values

Type II network, divided values. Interestingly most of the proteins in the first 100 positions in this table would occur in the divided ranks table between position 100 and 200, indicating a difference in emphasis between the two simulations but not in the overall function. The fully annotated table, include Ensembl gene identifiers and network values can be found in the supplementary data.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 1375 to 1424 of 3228 in total 
Value Type: Measured
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1375\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
calcium/calmodulin-dependent protein kinase type ii gamma chain (ec 2.7.1.123) (cam-kinase ii gamma chain) (cam kinase ii gamma subunit) (camk-ii gamma subunit) (fragment). [source:swissprot;acc:q13555]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6079.45\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6555.4\vspace{3pt}}&\multirow{13}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.07829\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1376\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
calcium/calmodulin-dependent protein kinase type ii delta chain (ec 2.7.1.123) (cam-kinase ii delta chain) (cam kinase ii delta subunit) (camk-ii delta subunit). [source:swissprot;acc:q13557]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6079.46\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
6555.41\vspace{3pt}}&\\\cline{1-2}\cline{4-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1377\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
mitogen-activated protein kinase kinase kinase 6 (ec 2.7.1.-). [source:swissprot;acc:o95382]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6555.4\vspace{3pt}}}&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1378\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
signal-induced proliferation-associated 1-like 1. [source:refseq;acc:nm\_015556]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6079.45\vspace{3pt}}&&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1379\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ribosomal protein s6 kinase alpha 1 (ec 2.7.1.37) (s6k-alpha 1) (90 kda ribosomal protein s6 kinase 1) (p90-rsk 1) (ribosomal s6 kinase 1) (rsk-1) (pp90rsk1). [source:swissprot;acc:q15418]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6079.46\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6555.41\vspace{3pt}}}&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1380\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
atp-binding cassette, sub-family d, member 3 (70 kda peroxisomal membrane protein) (pmp70). [source:swissprot;acc:p28288]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1381\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
glutaryl-coa dehydrogenase, mitochondrial precursor (ec 1.3.99.7) (gcd). [source:swissprot;acc:q92947]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1382\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
histidine ammonia-lyase (ec 4.3.1.3) (histidase). [source:swissprot;acc:p42357]\vspace{3pt}}&&&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1383\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ribosomal protein s6 kinase alpha 6 (ec 2.7.1.37) (s6k-alpha 6) (90 kda ribosomal protein s6 kinase 6) (p90-rsk 6) (ribosomal s6 kinase 4) (rsk-4) (pp90rsk4). [source:swissprot;acc:q9uk32]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6079.45\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6555.4\vspace{3pt}}}&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1384\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ribosomal protein s6 kinase alpha 2 (ec 2.7.1.37) (s6k-alpha 2) (90 kda ribosomal protein s6 kinase 2) (p90-rsk 2) (ribosomal s6 kinase 3) (rsk-3) (pp90rsk3). [source:swissprot;acc:q15349]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1385\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
calcium/calmodulin-dependent protein kinase type ii alpha chain (ec 2.7.1.123) (cam-kinase ii alpha chain) (cam kinase ii alpha subunit) (camk-ii alpha subunit). [source:swissprot;acc:q9uqm7]\vspace{3pt}}&&&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1386\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
calcium/calmodulin-dependent protein kinase type ii beta chain (ec 2.7.1.123) (cam-kinase ii beta chain) (cam kinase ii beta subunit) (camk-ii beta subunit). [source:swissprot;acc:q13554]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6079.46\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
6555.41\vspace{3pt}}&\\\cline{1-2}\cline{4-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1387\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
mitogen-activated protein kinase kinase kinase 5 (ec 2.7.1.-) (mapk/erk kinase kinase 5) (mek kinase 5) (mekk 5) (apoptosis signal- regulating kinase 1) (ask-1). [source:swissprot;acc:q99683]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6555.4\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1388\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
lin-7 homolog b; lin-7b protein; likely ortholog of mouse lin-7b; mammalian lin-7 protein 2; likely orholog of mouse lin 7 homolog b (c. elegans). [source:refseq;acc:nm\_022165]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5743.39\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6192.94\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07827\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1389\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
mitogen-activated protein kinase 1 (ec 2.7.1.37) (extracellular signal-regulated kinase 2) (erk-2) (mitogen-activated protein kinase 2) (map kinase 2) (mapk 2) (p42-mapk) (ert1). [source:swissprot;acc:p28482]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6079.13\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6554.85\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07825\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1390\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
receptor protein-tyrosine kinase erbb-4 precursor (ec 2.7.1.112) (p180erbb4) (tyrosine kinase-type cell surface receptor her4). [source:swissprot;acc:q15303]\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5743.36\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
6192.72\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.07824\vspace{3pt}}}\\\cline{1-2}\cline{4-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1391\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
epidermal growth factor receptor precursor (ec 2.7.1.112) (receptor protein-tyrosine kinase erbb-1). [source:swissprot;acc:p00533]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6192.7\vspace{3pt}}}&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1392\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
receptor protein-tyrosine kinase erbb-2 precursor (ec 2.7.1.112) (p185erbb2) (neu proto-oncogene) (c-erbb-2) (tyrosine kinase-type cell surface receptor her2) (mln 19). [source:swissprot;acc:p04626]\vspace{3pt}}&&&\\\cline{1-2}\cline{4-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1393\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2-hydroxyphytanoyl-coa lyase (ec 4.1.-.-) (2-hpcl) (hspc279). [source:swissprot;acc:q9uj83]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6192.72\vspace{3pt}}}&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1394\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
receptor protein-tyrosine kinase erbb-3 precursor (ec 2.7.1.112) (c-erbb3) (tyrosine kinase-type cell surface receptor her3). [source:swissprot;acc:p21860]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1395\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
lin-7 homolog c; lin-7 protein 3. [source:refseq;acc:nm\_018362]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5743.26\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6191.96\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07813\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1396\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
g-rich sequence factor-1 (grsf-1). [source:swissprot;acc:q12849]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5803.54\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6256.54\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07806\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1397\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
heterogeneous nuclear ribonucleoprotein f (hnrnp f). [source:swissprot;acc:p52597]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5803.27\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6256.23\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.07805\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1398\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
heterogeneous nuclear ribonucleoprotein h (hnrnp h). [source:swissprot;acc:p31943]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5803.12\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6256.05\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1399\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
heterogeneous nuclear ribonucleoprotein h' (hnrnp h') (ftp-3). [source:swissprot;acc:p55795]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5803.1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6256.03\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1400\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
heterogeneous nuclear ribonucleoprotein h3 (hnrnp h3) (hnrnp 2h9). [source:swissprot;acc:p31942]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5803.45\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6256.43\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1401\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
hepatocyte nuclear factor 3-gamma (hnf-3g) (forkhead box protein a3) (fork head-related protein fkh h3). [source:swissprot;acc:p55318]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5728.92\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6175.99\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.07804\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1402\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
43 kda receptor-associated protein of the synapse (rapsyn) (acetylcholine receptor-associated 43 kda protein) (43 kda postsynaptic protein). [source:swissprot;acc:q13702]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6160.06\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6640.78\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1403\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
importin 4. [source:refseq;acc:nm\_024658]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5613.16\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6050.16\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07785\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1404\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
mesoderm induction early response 1. [source:refseq;acc:nm\_020948]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6291.89\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6781.6\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.07783\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1405\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
proteasome subunit alpha type 3 (ec 3.4.25.1) (proteasome component c8) (macropain subunit c8) (multicatalytic endopeptidase complex subunit c8). [source:swissprot;acc:p25788]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1406\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ribokinase (ec 2.7.1.15). [source:swissprot;acc:q9h477]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6210.51\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6693.49\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07777\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1407\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
transketolase (ec 2.2.1.1) (tk). [source:swissprot;acc:p29401]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5692.53\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6134.64\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07766\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1408\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
serologically defined colon cancer antigen 16. [source:refseq;acc:nm\_006649]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6268.94\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6755.57\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07763\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1409\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
glucosamine--fructose-6-phosphate aminotransferase [isomerizing] 2 (ec 2.6.1.16) (hexosephosphate aminotransferase 2) (d-fructose-6- phosphate amidotransferase 2) (gfat 2) (gfat2). [source:swissprot;acc:o94808]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5358.19\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5773.37\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07749\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1410\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
delta-interacting protein a (hepatitis delta antigen interacting protein a). [source:swissprot;acc:q15834]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6274.62\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6760.78\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07748\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1411\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
14-3-3 protein beta/alpha (protein kinase c inhibitor protein-1) (kcip-1) (protein 1054). [source:swissprot;acc:p31946]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5812.02\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6262.07\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07743\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1412\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
histone deacetylase 5 (hd5) (antigen ny-co-9). [source:swissprot;acc:q9uql6]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5813.84\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6263.92\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.07742\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1413\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
histone deacetylase 9 (hd9) (hd7b) (hd7). [source:swissprot;acc:q9ukv0]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5813.88\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
6263.97\vspace{3pt}}&\\\cline{1-2}\cline{4-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1414\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
histone deacetylase 4 (hd4). [source:swissprot;acc:p56524]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6263.96\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07741\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1415\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
14-3-3 protein zeta/delta (protein kinase c inhibitor protein-1) (kcip-1) (factor activating exoenzyme s) (fas). [source:swissprot;acc:p29312]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5815.33\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6265.44\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.0774\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1416\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
xpmc2 prevents mitotic catastrophe 2 homolog; xenopus prevents mitotic catastrophe 2 homolog. [source:refseq;acc:nm\_020385]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6123.75\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6597.71\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1417\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
isocitrate dehydrogenase [nad] subunit alpha, mitochondrial precursor (ec 1.1.1.41) (isocitric dehydrogenase) (nad+-specific icdh). [source:swissprot;acc:p50213]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5360.39\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5775.24\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.07739\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1418\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
isocitrate dehydrogenase [nad] subunit beta, mitochondrial precursor (ec 1.1.1.41) (isocitric dehydrogenase) (nad+-specific icdh). [source:swissprot;acc:o43837]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1419\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
isocitrate dehydrogenase [nad] subunit gamma, mitochondrial precursor (ec 1.1.1.41) (isocitric dehydrogenase) (nad+-specific icdh). [source:swissprot;acc:p51553]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1420\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
zinc finger protein zic 1 (zinc finger protein of the cerebellum 1). [source:swissprot;acc:q15915]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5658.51\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6096.21\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07735\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1421\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
importin 7; ran-binding protein 7. [source:refseq;acc:nm\_006391]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5628.53\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6063.61\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.0773\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1422\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
importin 8; ran-binding protein 8. [source:refseq;acc:nm\_006390]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1423\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
brefeldin a-inhibited guanine nucleotide-exchange protein 2 (brefeldin a-inhibited gep 2). [source:swissprot;acc:q9y6d5]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1424\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
hsgcn1 (fragment). [source:sptrembl;acc:q99736]\vspace{3pt}}&&&\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/